Skip to main content

Advertisement

SpringerLink
Log in

Polypharmacy in elderly patients with type 2 diabetes receiving oral antidiabetic treatment

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Aim

Polypharmacy in older diabetics can have detrimental effects linked to poor adherence and the risk of drug interaction or more serious/frequent side effects. The aim of this study was to identify the characteristics associated with polypharmacy in a cohort of elderly diabetic patients being treated with oral hypoglycemic agents.

Methods

The study population consisted of 1342 diabetic patients consecutively enrolled in 57 diabetes centers in Italy participating in the METABOLIC Study. Patients meeting the following inclusion criteria were enrolled: diagnosis of type 2 diabetes mellitus, age ≥65 years, and receiving oral antidiabetic treatment. Data concerning diabetes duration and complications, the medications the patients were taking, and the number of hypoglycemic events were registered. Multidimensional impairment was assessed using the Multidimensional Prognostic Index.

Results

The mean age of the participants was 73.3 ± 5.5 years. Polypharmacy, defined as being prescribed contemporaneously at least five drugs, was found in 57.1 % of the study population. According to a multivariable logistic model, the female gender was significantly associated with polypharmacy, as were living in Northern Italian regions, diabetes duration longer than 4 years, and having a body mass index ≥30 kg/m2. Comorbidities, diabetes complications, a better cognitive performance on the Short Portable Mental Status Questionnaire, and being malnourished/at risk of malnourishment according to the mini nutritional assessment were associated with polypharmacy.

Conclusions

Polypharmacy, a condition that may lead to many potential detrimental outcomes in older diabetic subjects, was significantly associated with some risk factors that may be useful to identify subjects at risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Dardano A, Penno G, Del Prato S, Miccoli R (2014) Optimal therapy of type 2 diabetes: a controversial challenge. Aging (Albany NY) 6(3):187–206

    Article  CAS  Google Scholar 

  2. Selvin E, Coresh J, Brancati FL (2006) The burden and treatment of diabetes in elderly individuals in the US. Diabetes Care 29(11):2415–2419

    Article  PubMed  Google Scholar 

  3. Ubink-Veltmaat LJ, Bilo HJ, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B (2003) Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in The Netherlands (ZODIAC-1). Eur J Epidemiol 18(8):793–800

    Article  CAS  PubMed  Google Scholar 

  4. Emslie-Smith A, Dowall J, Morris A (2003) The problem of polypharmacy in type 2 diabetes. Br J Diabetes Vasc Dis 3(1):54–56

    Article  Google Scholar 

  5. Bauer S, Nauck MA (2014) Polypharmacy in people with type 1 and type 2 diabetes is justified by current guidelines—a comprehensive assessment of drug prescriptions in patients needing inpatient treatment for diabetes-associated problems. Diabet Med 31(9):1078–1085

    Article  CAS  PubMed  Google Scholar 

  6. Chelliah A, Burge MR (2004) Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention. Drugs Aging 21(8):511–530

    Article  CAS  PubMed  Google Scholar 

  7. Peron EP, Ogbonna KC, Donohoe KL (2015) Antidiabetic medications and polypharmacy. Clin Geriatr Med 31(1):17–27. doi:10.1016/j.cger.2014.08.017

    Article  PubMed  Google Scholar 

  8. Sergi G, De Rui M, Sarti S, Manzato E (2011) Polypharmacy in the elderly: can comprehensive geriatric assessment reduce inappropriate medication use? Drugs Aging 28(7):509–518

    Article  PubMed  Google Scholar 

  9. Maggi S, Noale M, Pilotto A, Tiengo A, Cavallo Perin P, Crepaldi G, for the Metabolic Working Group (2013) The METABOLIC Study: multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatment. Diabetes Metab 39:236–243

    Article  CAS  PubMed  Google Scholar 

  10. Pilotto A, Noale M, Maggi S, Addante F, Tiengo A, Perin PC, Rengo G, Crepaldi G (2014) Hypoglycemia is independently associated with multidimensional impairment in elderly diabetic patients. Biomed Res Int 2014:906103

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Pilotto A, Ferrucci L, Franceschi M, D’Ambrosio LP, Scarcelli C, Cascavilla L, Paris F, Placentino G, Seripa D, Dallapiccola B, Leandro G (2008) Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res 11(1):151–161

    Article  PubMed  PubMed Central  Google Scholar 

  12. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychological function. JAMA 185:914–919

    Article  CAS  PubMed  Google Scholar 

  13. Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179–186

    Article  CAS  PubMed  Google Scholar 

  14. Pfeiffer E (1975) A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 23:433–441

    Article  CAS  PubMed  Google Scholar 

  15. Bliss MR, McLaren R, Exton-Smith AN (1966) Mattresses for preventing pressure sores in geriatric patients. Mon Bull Minist Health Public Health Lab Serv 25:238–268

    CAS  PubMed  Google Scholar 

  16. Conwell Y, Forbes NT, Cox C, Caine ED (1993) Validation of a measure of physical illness burden at autopsy: the Cumulative Illness Rating Scale. J Am Geriatr Soc 41:38–41

    Article  CAS  PubMed  Google Scholar 

  17. Vellas B, Guigoz Y, Garry PJ, Nourhashemi F, Bennahum D, Lauque S et al (1999) The mini nutritional assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 15:116–122

    Article  CAS  PubMed  Google Scholar 

  18. Gallucci M, Battistella G, Bergamelli C, Spagnolo P, Mazzuco S, Carlini A, Di Giorgi E, Boldrini P, Pilotto A (2014) Multidimensional prognostic index in a cognitive impairment outpatient setting: mortality and hospitalizations. The treviso dementia (TREDEM) study. J Alzheimers Dis 42:1461–1468

    PubMed  Google Scholar 

  19. Pilotto A, Gallina P, Fontana A, Sancarlo D, Bazzano S, Copetti M, Maggi S, Paroni G, Marcato F, Pellegrini F, Donato D, Ferrucci L (2013) Development and validation of a Multidimensional Prognostic Index for mortality based on a standardized multidimensional assessment schedule (MPI-SVaMA) in community-dwelling older subjects. J Am Med Dir Assoc 14:287–292

    Article  PubMed  Google Scholar 

  20. Blanco-Reina E, Ariza-Zafra G, Ocaña-Riola R, León-Ortíz M, Bellido-Estévez I (2015) Optimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related? Eur J Clin Pharmacol 71(2):199–207

    Article  CAS  PubMed  Google Scholar 

  21. Payne RA, Avery AJ (2011) Polypharmacy: one of the greatest prescribing challenges in general practice. Br J Gen Pract 61(583):83–84

    Article  PubMed  PubMed Central  Google Scholar 

  22. Rochon PA, Gurwitz JH (1997) Optimising drug treatment for elderly people: the prescribing cascade. BMJ 315(7115):1096–1099

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Venturini CD, Engroff P, Ely LS, Zago LF, Schroeter G, Gomes I, De Carli GA, Morrone FB (2011) Gender differences, polypharmacy, and potential pharmacological interactions in the elderly. Clinics (Sao Paulo) 66(11):1867–1872

    Google Scholar 

  24. Jyrkkä J, Mursu J, Enlund H, Lönnroos E (2012) Polypharmacy and nutritional status in elderly people. Curr Opin Clin Nutr Metab Care 15(1):1–6

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The METABOLIC Study was supported by a research Grant from Sigma-Tau Industrie Farmaceutiche Riunite, Pomezia (Roma). The authors wish to thank Linda Inverso Moretti for reviewing the English version of this manuscript.

Author information

Author notes

    Authors and Affiliations

    1. CNR - Institute of Neuroscience, Aging Branch, Via Giustiniani 2, 35128, Padua, Italy

      Marianna Noale, Gaetano Crepaldi & Stefania Maggi

    2. Department of Medicine, University of Padua, Padua, Italy

      Nicola Veronese & Antonio Tiengo

    3. Diabetology Unit, University of Turin, Turin, Italy

      Paolo Cavallo Perin

    4. Geriatrics Unit, Azienda ULSS, 16, S. Antonio Hospital, Padua, Italy

      Alberto Pilotto

    Authors
    1. Marianna Noale
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Nicola Veronese
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Paolo Cavallo Perin
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Alberto Pilotto
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Antonio Tiengo
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Gaetano Crepaldi
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Stefania Maggi
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Marianna Noale.

    Ethics declarations

    Conflict of interest

    The authors declare that they have no conflict of interest.

    Ethical standard

    The study was approved by ethics review committees of each participating center.

    Human and animal rights

    All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.

    Informed consent

    Informed consent was obtained from all patients for being included in the study.

    Additional information

    Managed by Massimo Porta.

    Marianna Noale and Nicola Veronese have contributed equally to the study.

    Metabolic Working Group is listed in the section “Appendix”.

    Electronic supplementary material

    Below is the link to the electronic supplementary material.

    Supplementary material 1 (PDF 9 kb)

    Appendix: Metabolic Working Group

    Appendix: Metabolic Working Group

    Andrea Corsi, Aglioloro Alberto (Sampierdarena—GE); Allochis Gabriele (Novara); Aricò Concetta Nadia (Belluno); Balbo Marcella (Alessandria); Marangoni Alberto, Balzano Sara (Bassano del Grappa, VI); Battisti Basilio (Rieti); Testa Ivano, Brandoni Gabriele (Ancona); Bruno Alberto, Degiovanni Mariella (Torino); Buzzetti Raffaella, Foffi Chiara (Latina); Calatola Pasqualino (Salerno); Cantarella Santi Antonio (Canicattì—AG); Rondena Maurizio, Cimpanelli Maria Grazia (Legnano—MI); Confortin Loris (Castelfranco Veneto, TV); Consoli Agostino, Baldassarre Maria (Pescara); Invitti Cecilia, Conti Antonio (Milano); Del Prato Stefano, Crisci Isabella (Pisa); Derosa Giuseppe, Maffioli Pamela (Pavia); Devangelio Eleonora (Taranto); Di Bartolo Paolo (Ravenna);Ruggeri Patrizia, Di Lembo Sergio (Cremona); Di Mauro Maurizio, Battiato Rosario (Catania); Farci Fernando (Quartu S. Elena—CA); Fisicaro Michela (Nicosia—EN); Pontiroli Antonio, Folini Laura (Milano); Gargiulo Anna, Vinciguerra Antonio (Caserta); Giorgino Francesco, Laviola Luigi (Bari); Clementina Cazzalini, Guerini Stelio (Crema); Tonolo Giancarlo, Iwniszyn Dominika (Olbia); Lambiase Claudio (Mercato San Severino—SA); Leotta Sergio (Roma); Mangeri Felice (Brescia); Mangili Ruggero (Seriate—BG); Mattiuzzo Claudio (Tivoli—RM); Mollo Francesco (Rovigo); Novara Francesca, Gucciardi Paolo (Paceco—TP); Orsi Emanuela, Palmieri Eva (Milano); Pacifico Adolfo Arturo, Burruni Anna (Sassari); Pagani Giorgio, Albizzi Monica (Bergamo); Pasquini Cristina (Livorno); Cavallo Perin Paolo, Perotto Massimo (Torino); Piccolo Patrizia (Cosenza); Pilotto Alberto, D’Ambrosio Piero (San Giovanni Rotondo—FG); Maolo Gabriele, Polenta Barbara (Macerata); Purrello Francesco, Tomaselli Tania (Catania); Tardio Michele Sergio, Quarantelli Cristina (Parma); Ragusa Giorgio Salvatore (Scicli—RG); Borzì Vito, Rapisardi Riccardo (Catania); Richini Donata (Brescia); Rosco Maura (Bari); Serra Rosalia (Lecce): Marchesini Reggiani Giulio, Soverini Valentina (Bologna); Tiengo Antonio (Padova); Tomasi Franco (Ferrara); De Angelis Massimiliano, Turco Antonio (Perugia); Tolaini Patricia, Vangucci Silverio (Castelnuovo Garfagnana—LU); Zavaroni Ivana (Parma).

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Noale, M., Veronese, N., Cavallo Perin, P. et al. Polypharmacy in elderly patients with type 2 diabetes receiving oral antidiabetic treatment. Acta Diabetol 53, 323–330 (2016). https://doi.org/10.1007/s00592-015-0790-4

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s00592-015-0790-4

    Keywords

    Search

    Navigation